SECTOR:
Ablaze Pharma
FUND/VEHICLE:
Pivotal China
INVESTMENT DATE:
2021
GEOGRAPHY:
China
STATUS CURRENT/FORMER INVESTMENT:
Existing
WEBSITE:
Ablaze Pharma is a clinical stage Biopharmaceutical Company which is focused on the developing innovative Targeted Radiotherapy (TRT) to benefit cancer patients in China.